Medical grade Manuka antimicrobial properties

Few natural products have been studied for antimicrobial activity as thoroughly as Manuka honey. Yet walk down any supermarket aisle and you will struggle to find a Manuka jar that explicitly says “antibacterial” or “antimicrobial” on the label. That gap between the published science and what brands are allowed to say is the single biggest source of confusion for consumers — and it is exactly why the medical grade honey category exists as a separate, regulated product class for burns and wound care.

What makes Manuka honey antimicrobial

Manuka honey’s activity against bacteria is multi-modal — it does not rely on a single mechanism, which is part of why resistance has not been documented in the way it has for conventional antibiotics.

• Methylglyoxal (MGO) — Formed non-enzymatically from dihydroxyacetone (DHA) in Manuka nectar. MGO is the principal non-peroxide antibacterial compound and is heat- and enzyme-stable, which is why Manuka activity survives storage and dilution in wound fluid better than peroxide-only honeys.
• Hydrogen peroxide — Released slowly by the enzyme glucose oxidase when honey is diluted by exudate. Provides continuous low-level antibacterial cover without the tissue toxicity of pharmaceutical-strength peroxide.
• Low pH (3.2–4.5) — Acidic wound environments inhibit bacterial protease activity and support fibroblast function.
• High osmolarity — Honey’s ~80% sugar content draws water out of bacterial cells, suppressing growth.
• Bee defensin-1 — A small antimicrobial peptide contributed by the bee that adds activity against gram-positive organisms.

Why companies avoid “antimicrobial” claims on pack

This is the question that surprises most consumers. The science is published in peer-reviewed journals; hospitals use Manuka-based dressings every day. So why won’t the jar say so?

The answer is regulatory. In every major market, the moment a product makes a medicinal or antimicrobial claim, it stops being a food and becomes either a medicine or a medical device:

• UK — MHRA and the Food Standards Agency. Any claim to treat, prevent or cure disease triggers the Human Medicines Regulations 2012. “Antibacterial” on a food label is a borderline medicinal claim by function.
• EU — Regulation (EC) 1924/2006 on nutrition and health claims prohibits any health claim not on the authorised EFSA list. No antimicrobial claim for honey is on that list.
• USA — FDA classifies products by intended use. Saying honey “kills bacteria” on a food label reclassifies it as an unapproved drug, triggering enforcement letters.
• Australia / NZ — TGA and MPI enforce similar rules. New Zealand’s MPI also separately polices Manuka authenticity through the four-chemical + DNA test.

The compliant workaround the industry has settled on is to publish a laboratory potency grade — MGO (mg/kg of methylglyoxal), UMF (Unique Manuka Factor), or NPA (Non-Peroxide Activity) — without translating it into a health claim. A jar marked “MGO 550+” tells an informed buyer the antibacterial potential without the brand ever printing the regulated word.

That is also why the same Manuka honey, lifted from a food jar into a sterile tube, can suddenly be marketed for wound care: the product has been re-manufactured under ISO 13485 quality systems, sterilised, and CE/UKCA-marked as a medical device. The chemistry is the same; the legal status, sterility and intended use are completely different.

Medical grade honey for wound care

In a wound-care context, the same antimicrobial chemistry is delivered through sterile, certified dressings — tubes of honey gel, impregnated tulle dressings, alginate fibres saturated with honey, and hydrocolloid pads. The most widely used products in the UK and Europe are Activon (Advancis), Medihoney (Derma Sciences / Integra) and Algivon.

• Chronic wounds — Venous leg ulcers, pressure ulcers and diabetic foot ulcers benefit from honey’s combined debriding, antibacterial and moist-healing effects. NICE guidance recognises honey dressings as an option for sloughy or malodorous wounds.
• Surgical and trauma wounds — Used to manage dehisced surgical wounds, skin tears and infected post-op sites where antibiotic stewardship matters.
• Bioburden control — Reduces malodour and bacterial load, often within the first 2–3 dressing changes, and works against organisms including MRSA without driving resistance.

See our practical guide to using medical honey dressings and the Medihoney vs Activon comparison.

Medical grade honey for burns

On burns, the antimicrobial argument is even more directly relevant. Burn wounds are a high-risk infection environment, and silver-based dressings — long the default — have well-documented downsides including pain on removal and cytotoxicity at high concentrations. Randomised controlled trials of sterile honey dressings on partial-thickness burns have reported:

• Faster re-epithelialisation than silver sulfadiazine in several head-to-head studies.
• Lower bacterial colonisation at day 7.
• Comparable or better pain scores during dressing changes.

Full detail and a patient-friendly walkthrough is on our medical honey for burns page.

How to read a Manuka label

• MGO 100+ / 250+ / 550+ / 850+ — Minimum methylglyoxal content in mg/kg. Higher = more non-peroxide activity. Below ~MGO 100 the non-peroxide activity is negligible.
• UMF 5+ / 10+ / 15+ / 20+ — New Zealand certification mark combining MGO, leptosperin and DHA tests. Roughly: UMF 10+ ≈ MGO 250+, UMF 15+ ≈ MGO 550+, UMF 20+ ≈ MGO 850+.
• K-Factor, TA, “Active” — Brand-owned terms with looser standards. Treat as marketing unless backed by an MGO or UMF number.
• CE / UKCA mark + lot number + “sterile” — The only labelling that means the product is safe for use on broken skin.

Frequently asked questions

Related reading

• Manuka vs medical grade honey
• Medical grade honey for burns
• How to use a medical honey dressing
• Medical honey for diabetic foot ulcers
• What makes a honey “medical grade”
• Research & evidence